Hasil Pencarian - Qi-Long Yi

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients

    Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients oleh Maciej Witkos, Qi-Long Yi, Jenny Heathcote, Moira K Kapral, Murray D Krahn

    Diterbitkan 2006-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron

    SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron oleh Sheila F. O’Brien, Niamh Caffrey, Qi-Long Yi, Chantale Pambrun, Steven J. Drews

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era

    Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era oleh Cassandra N. Reedman, Steven J. Drews, Qi-Long Yi, Chantale Pambrun, Sheila F. O’Brien

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against Staphylococcus aureus Biofilms

    Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against Staphylococcus aureus Biofilms oleh Dilini Kumaran, Mariam Taha, QiLong Yi, Sandra Ramirez-Arcos, Jean-Simon Diallo, Alberto Carli, Hesham Abdelbary, Hesham Abdelbary

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History

    SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History oleh Steven J. Drews, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Qi-Long Yi, Sheila F. O’Brien

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets.

    The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets. oleh Maria Loza-Correa, Juan A Ayala, Iris Perelman, Keith Hubbard, Miloslav Kalab, Qi-Long Yi, Mariam Taha, Miguel A de Pedro, Sandra Ramirez-Arcos

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance

    Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance oleh Sheila F. O’Brien, Cassandra N. Reedman, Carla Osiowy, Shelly Bolotin, Qi-Long Yi, Lillian Lourenço, Antoine Lewin, Mawuena Binka, Niamh Caffrey, Steven J. Drews

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays

    Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays oleh Ashleigh R. Tuite, David Fisman, Kento T. Abe, Bhavisha Rathod, Adrian Pasculescu, Karen Colwill, Anne-Claude Gingras, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021

    A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to... oleh Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Ninette F. Robbins, Guillermo Orjuela, Craig Jenkins, Valerie Conrod, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. oleh Sahar Saeed, Sheila F O'Brien, Kento Abe, Qi-Long Yi, Bhavisha Rathod, Jenny Wang, Mahya Fazel-Zarandi, Ashleigh Tuite, David Fisman, Heidi Wood, Karen Colwill, Anne-Claude Gingras, Steven J Drews

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021

    Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 oleh Yi-Chan J. Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health

    Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health oleh Sheila F. O’Brien, Niamh Caffrey, Qi-Long Yi, Shelly Bolotin, Naveed Z. Janjua, Mawuena Binka, Caroline Quach Thanh, Derek R. Stein, Amanda Lang, Amy Colquhoun, Chantale Pambrun, Cassandra N. Reedman, Steven J. Drews

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses

    Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses oleh Yi-Chan J. Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: